Our DNA tells the story of who we are genetically. But when we develop cancer, our tumor DNA tells a different version of that story.
At Ashion Analytics, a subsidiary of TGen, a patient's tumor sample undergoes testing in a CLIA-certified laboratory —through its flagship test, GEM ExTra— to understand how the story changed and how Ashion can help treating physicians identify actionable steps to help their patients.
In episode 24 of TGen Talks, Dr. Janine LoBello, Medical Director and Pathologist of Ashion Analytics, discusses Ashion's beginnings, how their services benefit medical professionals, and a few interesting facts you may not know about the BReast CAncer, or BRCA, gene.
Listen now or learn more at ashion.com.

Ver todos los episodios